Campbell Rogers - 12 Feb 2026 Form 4 Insider Report for Heartflow, Inc. (HTFL)

Role
Chief Medical Officer
Signature
/s/ Mhairi Jones, by power of attorney
Issuer symbol
HTFL
Transactions as of
12 Feb 2026
Net transactions value
-$1,204,089
Form type
4
Filing time
17 Feb 2026, 20:07:50 UTC
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rogers Campbell Chief Medical Officer C/O HEARTFLOW, INC., 331 E. EVELYN AVENUE, MOUNTAIN VIEW /s/ Mhairi Jones, by power of attorney 17 Feb 2026 0001585724

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HTFL Common Stock Options Exercise $43,070 +19,401 +26% $2.22 93,572 12 Feb 2026 Direct F1
transaction HTFL Common Stock Options Exercise $330,776 +39,709 +42% $8.33 133,281 12 Feb 2026 Direct F2
transaction HTFL Common Stock Options Exercise $17,551 +7,906 +5.9% $2.22 141,187 12 Feb 2026 Direct F2
transaction HTFL Common Stock Sale $1,595,486 -65,153 -46% $24.49 76,034 12 Feb 2026 Direct F3, F4
holding HTFL Common Stock 22,615 12 Feb 2026 By Campbell Rogers 2019 Irrevocable Trust
holding HTFL Common Stock 46,159 12 Feb 2026 By CR Asset Protection Trust of 2023
holding HTFL Common Stock 26,012 12 Feb 2026 By Spouse's Trust
holding HTFL Common Stock 50,754 12 Feb 2026 By The Campbell Rogers Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HTFL Stock Option Options Exercise $0 -39,709 -100% $0.000000 0 12 Feb 2026 Common Stock 39,709 $8.33 Direct F2, F5
transaction HTFL Stock Option Options Exercise $0 -19,401 -8.2% $0.000000 216,433 12 Feb 2026 Common Stock 19,401 $2.22 Direct F1, F6
transaction HTFL Stock Option Options Exercise $0 -7,906 -3.7% $0.000000 208,527 12 Feb 2026 Common Stock 7,906 $2.22 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
F2 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
F3 Includes the sale of 17,538 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
F4 This transaction was executed in multiple trades at price ranging from $22.90 to $26.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 These stock options are fully exercisable.
F6 The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.